What Is GILD Fair Value?
Gilead Sciences Inc. (GILD) fair value estimate using multiple valuation models, updated daily.
As of August 1, 2026, Gilead Sciences Inc. (GILD) has a composite fair value estimate of $120.50 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $130.21, suggesting the stock is fair value by 7.5%.
Data as of August 1, 2026 (today)
Composite Fair Value
Fair Value4 of 4 models$120.50
vs. current price of $130.21(-7.5%)
How Is GILD Fair Value Calculated?
Four independent models estimate what GILD is worth. Each uses different inputs and assumptions. The composite blends them by weight.
GILD Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$182.61
+40.2%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$86.50
-33.6%Overvalued
Inputs used
GILD Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$55.92
-57.1%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$73.40
-43.6%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $130.21 is 40.2% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $8.33B | $7.85B |
| Year 2 | $8.75B | $7.77B |
| Year 3 | $9.18B | $7.69B |
| Year 4 | $9.64B | $7.61B |
| Year 5 | $10.13B | $7.53B |
| Year 6 | $10.63B | $7.46B |
| Year 7 | $11.16B | $7.38B |
| Year 8 | $11.72B | $7.30B |
| Year 9 | $12.31B | $7.23B |
| Year 10 | $12.92B | $7.15B |
| Terminal Value | $368.73B | $204.10B |
What Are GILD's Key Financial Metrics?
Earnings & Growth
Current Price
$130.21
EPS (TTM)
$7.34
Forward P/E
13.5
Profit Margin
31.0%
Cash & Balance Sheet
Free Cash Flow
7.9B
EBITDA
14.7B
Book Value
$18.93
Total Debt
22.2B
What Do Analysts Say About GILD?
Low
$120.00
Average
$157.15
High
$180.00
Upside
+20.7%
GILD Fair Value FAQ
What is the fair value of GILD?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), GILD's estimated fair value is $120.50. The stock is currently trading at $130.21, which makes it fair value by our analysis.
How is GILD's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is GILD overvalued or undervalued?
Based on our analysis, GILD is fair value. The current price of $130.21 is 7.5% above our estimated fair value of $120.50.
What do Wall Street analysts say about GILD?
27 analysts cover Gilead Sciences Inc. with a consensus rating of "Buy." The average price target is $157.15, ranging from $120.00 to $180.00. This implies 20.7% upside from the current price.